Mahana Therapeutics Selected for Prestigious Digitalhealth.London Accelerator Program

Mahana IBS recognized as a digital solution with high potential to meet London's NHS and social care challenges Mahana Therapeutics, a leading developer of prescription digital therapeutics designed

Related Keywords

United Kingdom ,Greater London ,United Kingdom General ,London ,City Of ,Jenny Thomas ,Kostenloser Wertpapierhandel ,Sonia Patel ,Jon Scholefield ,Michele Parisi ,London National Health Service ,European Regional Development Fund ,England European Regional Development Fund ,Investment Funds Growth Programme ,Ministry Of Housing ,Authority For European Regional Development Fund ,European Union ,Greater London Authority ,Digitalhealth London ,Mahana Therapeutics ,National Health Service ,Digitalhealth London Accelerator ,Mahana United Kingdom Operations ,Health London ,Academic Health Science Networks ,Health Innovation Network ,European Structural ,Investment Funds Growth ,Sinai Accelerator ,Local Government ,Managing Authority ,European Regional Development ,Mahana ,Herapeutics ,Elected ,Restigious ,Igitalhealth ,Accelerator ,Program ,